Tecan to present at J.P. Morgan Healthcare Conference
January 08 2018 - 5:00AM
YASTEST
Tecan Group AG / Tecan to present at J.P. Morgan Healthcare
Conference . Processed and transmitted by Nasdaq Corporate
Solutions. The issuer is solely responsible for the content of this
announcement.
Männedorf, Switzerland, January 8, 2018 - The Tecan
Group (SIX Swiss Exchange: TECN) today announced that it will
present at J.P. Morgan Healthcare Conference on January 11,
2018.
The investor
presentation by David Martyr, CEO of Tecan, will begin at 9:30 am
PST (6:30 pm CET) and will be webcast live. The webcast may be
accessed under the "Investor Relations" tab of Tecan's website
www.tecan.com.
A replay of the webcast
will be available after the presentation and will remain available
for 90 days.
About
Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory
instruments and solutions in biopharmaceuticals, forensics and
clinical diagnostics. The company specializes in the development,
production and distribution of automated workflow solutions for
laboratories in the life sciences sector. Its clients include
pharmaceutical and biotechnology companies, university research
departments, forensic and diagnostic laboratories. As an original
equipment manufacturer (OEM), Tecan is also a leader in developing
and manufacturing OEM instruments and components that are then
distributed by partner companies. Founded in Switzerland in 1980,
the company has manuÂfacturing, research and development sites in
both Europe and North America and maintains a sales and service
network in 52 countries. In 2016, Tecan generated sales of CHF 506
million (USD 511 million; EUR 464 million). Registered shares of
Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN
CH0012100191).
For
further information:
Tecan
Group
Martin Braendle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com
Press Release
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Tecan Group AG via Globenewswire
--- End of Message ---
Tecan Group AG
Seestrasse 103 Maennedorf Switzerland
ISIN: CH0012100191;